Jeffrey S Damrauer

13PUBLICATIONS
50CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 12, 2026
Blinded by the Smoke: Are We Ignoring a Key Modifier of Response in Nonmuscle-Invasive Bladder Cancer Trials?

|Dec 13, 2025
APOBEC3 promotes squamous differentiation via IL-1A/AP-1 signaling.

Michael S Sturdivant, Andrew S Truong, Mi Zhou

|Jun 20, 2025
Correction: An FGFR-p53 developmental signaling axis drives salivary cancer progression.

Adele M Musicant, Julia M R Billington, Jeffrey S Damrauer

|Jun 02, 2025
An FGFR-p53 developmental signaling axis drives salivary cancer progression.

Adele M Musicant, Julia M R Billington, Jeffrey S Damrauer

|Aug 08, 2024
Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features.

N Ari Wijetunga, Kathryn H Gessner, Krishna Kanchi

|May 24, 2024
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer.

Wolfgang Beckabir, Mi Zhou, Jin Seok Lee

Pageof 3

Frequent Collaborators

6 joint publications

William Y Kim

4 joint publications

Matthew I Milowsky

4 joint publications

Katherine A Hoadley

3 joint publications

Mi Zhou